Skip to content

CG Oncology CGON Operating margin

Operating margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%+2.8pp
Gilead Sciences logo
Gilead SciencesGILD
34.9%+6.3pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-185.4%-83.3pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-206.2%-61.0pp
Summit Therapeutics logo
Summit TherapeuticsSMMT
-268,266.8%-272,316pp
Exelixis logo
ExelixisEXEL
39.4%+6.3pp

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%

Profitability

See full
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

Based on trailing twelve months.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's operating margin?
CG Oncology (CGON) reported operating margin of -4,239% in Q1 2026.
How has CG Oncology's operating margin changed year-over-year?
CG Oncology's operating margin increased by 79.1% year-over-year, from -20,302.3% to -4,239%.
What is the long-term trend for CG Oncology's operating margin?
Over 2 years (2023 to 2025), CG Oncology's operating margin has grown at a -58.3% compound annual growth rate (CAGR), from -27,178.9% to -4,722.1%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.